Trials / Withdrawn
WithdrawnNCT01857492
tDCS for the Management of Chronic Visceral Pain in Patients With Chronic Pancreatitis
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is testing whether the addition of a noninvasive form of brain stimulation called transcranial direct current stimulation (tDCS) when combined with meditation helps decrease the abdominal pain in patients with chronic pancreatitis. The device involved in this study, transcranial direct current stimulation (tDCS) is investigational. This means that the study device is still being tested in research studies and is not approved by the Food and Drug Administration \[FDA\].
Detailed description
This is a double-blind, pilot study with the goal of testing the effects of tDCS coupled with meditation in the management of visceral pain in patients with chronic pancreatitis. We will enroll a total of 14 subjects with chronic pancreatitis. After enrollment, subjects will be randomized to active stimulation plus mediation (7 subjects) or sham stimulation plus meditation (7 subjects). Subjects will undergo 5 days of active tDCS stimulation plus meditation or sham tDCS plus meditation. Sessions will last approximately 30 min - 1 hour. EEG activity will be measured in the first, last and follow-up visits. After each stimulation session, we will assess for adverse effects using the tDCS adverse effects questionnaire. We will also have the subject fill out a pain/medication diary during the 5 days of treatment. All study procedures will be completed at BIDMC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | tDCS | |
| BEHAVIORAL | Meditation | Both Active and SHAM groups will receive Meditation. |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2013-05-20
- Last updated
- 2015-03-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01857492. Inclusion in this directory is not an endorsement.